Simon Zhou
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 18
- Oncology 22
- Cancer Treatment and Pharmacology 12
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Duxin Sun (12 shared papers)Wei Gao (4 shared papers)Hongxiang Hu (4 shared papers)Maria Palmisano (46 shared papers)Nianhang Chen (17 shared papers)Rajesh Chopra (4 shared papers)Yan Li (22 shared papers)Donald G. Raible (3 shared papers)
- Journals
- Clinical Pharmacology Advances and Applications (9 papers)The Journal of Clinical Pharmacology (9 papers)Cancer Chemotherapy and Pharmacology (6 papers)Pharmaceutical Research (4 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Simon Zhou
71 papers receiving 2.6k citations
Simon Zhou's Hit Papers
Peers
Comparison fields: 5 of 146
- Biomaterials 303
- Pharmaceutical Science 127
- Hematology 213
- Pharmacology 158
- Oncology 459
Countries citing papers authored by Simon Zhou
This map shows the geographic impact of Simon Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Zhou more than expected).
Fields of papers citing papers by Simon Zhou
This network shows the impact of papers produced by Simon Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Zhou. The network helps show where Simon Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Why 90% of clinical drug development fails and how to improve it? Hit paper breakdown → | 2022 | 1010 |
| 2 | 2020 | 215 | |
| 3 | 2010 | 191 | |
| 4 | 2012 | 113 | |
| 5 | 2015 | 98 | |
| 6 | 2014 | 97 | |
| 7 | 2016 | 60 | |
| 8 | 2011 | 58 | |
| 9 | 2021 | 53 | |
| 10 | 2017 | 51 | |
| 11 | 1999 | 50 | |
| 12 | 2015 | 42 | |
| 13 | 2014 | 32 | |
| 14 | 2016 | 31 | |
| 15 | 2015 | 31 | |
| 16 | 1998 | 31 | |
| 17 | 2005 | 29 | |
| 18 | 1999 | 26 | |
| 19 | 2014 | 26 | |
| 20 | 2019 | 26 |
About Simon Zhou
Simon Zhou is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Biomaterials, having authored 71 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Cancer Treatment and Pharmacology (12 papers), Protein Degradation and Inhibitors (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Nanoparticle-Based Drug Delivery (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Biomaterials (303 citations), Pharmaceutical Science (127 citations), Hematology (213 citations), Pharmacology (158 citations) and Oncology (459 citations). Simon Zhou has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Duxin Sun, Wei Gao, Hongxiang Hu, Maria Palmisano, Nianhang Chen, Rajesh Chopra, Yan Li, Donald G. Raible, David Fleisher and Ying Ye. Their work appears in journals such as Clinical Pharmacology Advances and Applications, The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Pharmaceutical Research and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.